Richard Gaster - Profile and Investment Details

Investor Profile

Richard Gaster is a Private Equity Firm, Investor, Venture Capital based in San Francisco, California, United States with a diverse investment portfolio that includes companies such as Attralus, Aurinia Pharmaceuticals, Labrys Biologics, Adaptimmune, Metacrine, Seragon Pharmaceuticals, NorthSea Therapeutics, Solstice Biologics, Outlook Therapeutics, Stargazer Pharmaceuticals, Heart Metabolics, Turning Point Therapeutics, Precision BioSciences, Aeovian Pharmaceuticals, Akero Therapeutics, Harmony Biosciences, RayzeBio, Ventyx Biosciences, Elevation Oncology, ALX Oncology, Impel NeuroPharma, Checkmate Pharmaceuticals, Apellis Pharmaceuticals, Tallac Therapeutics, Bellicum Pharmaceuticals, Cytos, Artiva Biotherapeutics, Stem Cell Therapeutics, VYNE Therapeutics, Cidara Therapeutics, Arrakis Therapeutics, INBRACE, Pharvaris, Neurogastrx, NFlection Therapeutics, Aragon Pharmaceuticals, Fog Pharmaceuticals. Over time, Richard Gaster has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Richard Gaster is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Women Founded, Life Science, Biotech, Medical Device, Manufacturing, Healthcare, Biotechnology, Health and Hospital Services, Health IT, Digital Health, Medical, Therapeutics, Media and Entertainment, Pharmaceuticals, Biopharma may find it worthwhile to explore potential connections with Richard Gaster, as their portfolio suggests a familiarity and interest in this area.

Understanding Richard Gaster’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.